Mitochondrial DNA methylation in metabolic associated fatty liver disease

Keyphrases

• Mitochondrial DNA Methylation 100%
• Metabolic Dysfunction-associated Fatty Liver Disease (MAFLD) 100%
• Mitochondrial Dysfunction 33%
• Lipid Accumulation 33%
• Mitochondrial DNA 33%
• HepG2 Cells 33%
• Pyrosequencing 33%
• Cytosine 33%
• HepG2 33%
• Hepatic Lipid Accumulation 33%
• Methylation 16%
• Fatty Acids 16%
• Gene Expression 16%
• Viral 16%
• Metabolic Activity 16%
• Patient Samples 16%
• Gene Body 16%
• Acid Treatment 16%
• High Cholesterol 16%
• Quantitative Methylation-specific PCR (Q-MSP) 16%
• Mitochondrial Genes 16%
• Lipid Metabolism 16%
• CpG Methylation 16%
• Molecular Parameters 16%
• Mitochondrial Targeting 16%
• Human Patients 16%
• Differential Methylation 16%
• Liver Disease Progression 16%
• DNA Methyltransferase 1 (DNMT1) 16%
• DNA Hypermethylation 16%
• Mitochondrial Gene Expression 16%
• Nanopore Sequencing 16%
• Mitochondrial DNA Content 16%
• Simple Steatosis 16%
• Lipid Metabolic 16%
• Gene Expression Activity 16%
• Dysfunctional Mitochondria 16%
• Cytosine Methylation 16%
• Metabolic Dysfunction-associated Steatohepatitis 16%

Biochemistry, Genetics and Molecular Biology

• DNA Methylation 100%
• Mitochondrial DNA 100%
• Methylation 55%
• Lipid Storage 44%
• Cytosine 33%
• Mitochondrial Gene 22%
• Gene Expression 22%
• Mitochondrion 22%
• Lipid Liver Level 22%
• Mitochondrial Disorder 22%
• Lipid Metabolism 11%
• Pyrosequencing 11%
• DNA Methyltransferase 11%
• DNA Content 11%
• Hypercholesterolemia 11%
• Fatty Acid 11%